April 5, 2022   NEWS

Brain-disease trials help drug developer buck biotech sell-off

AUCKLAND: Orphan drug developer Neuren Pharmaceuticals is bucking the biotech sell-off. Its share price has

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In